Qing Sarah Yuan

Qing Sarah Yuan discloses dealings in Sigilon Therapeutics, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 27 July 2023 to 11 August 2023.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 11 August 2023, the filings show a transaction in Sigilon Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.